Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Reduced Incidence of Severe Hemorrhagic Cystitis in Prophylaxis Infusion of Mensenchymal Stromal Cells for Gvhd, a Secondary Endpoints in a Randomized,Multiple Center Clinical Tria

Han Yao, Xiaoqi Wang, Ruihao Huang, Yimei Feng, Xiaojuan Deng, Ting Chen, Lidan Zhu, Jia Liu, Yuqing Liu, Lu Zhao, Lu Wang, Cheng Zhang, Peiyan Kong, Li Gao, Lei Gao, Qifa Liu, Xiaohui Zhang, Xi Zhang

Blood (2024) 144 (Supplement 1): 7122.

https://doi.org/10.1182/blood-2024-206679

Published: 2024

Journal Articles

A Single-Arm, Multi-Center, Retrospective Clinical Study of Cba Preconditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Acute Leukemia

Dingjun Zhuo, Xu Tan, Guo Chen, Yingying Ma, Maihong Wang, Siyu Chen, Qin Wen, Hong Liu, Cheng Zhang, Xi Zhang

Blood (2024) 144 (Supplement 1): 7120.

https://doi.org/10.1182/blood-2024-206275

Published: 2024

Journal Articles

Efficacy and Safety of Decitabine Combined with FB3 As Conditional Regimen for Elderly/Frail Acute Myeloid Leukemia Patient with Allo-HSCT

Shichun Gao, Lidan Zhu, Jia Liu, Huanfeng Liu, Lu Wang, Peiyan Kong, Cheng Zhang, Li Gao, Ting Chen, Yimei Feng, Yuqing Liu, Han Yao, Lu Zhao, Lei Gao, Xi Zhang

Blood (2024) 144 (Supplement 1): 7317.

https://doi.org/10.1182/blood-2024-207037

Published: 2024

Journal Articles

Comparison of the Efficacy and Adverse Effects of Recipient-Derived Versus Donor-Derived CAR-T Cell Therapy for Post-Transplant Relapse in B-ALL

Lichao Liu, Ruihao Huang, Yongxian Hu, Sanfang Tu, Na Wang, Hai Yi, Qiuying Gao, Jian Zhou, Xiaoqi Wang, Cheng Zhang, Xi Zhang

Blood (2024) 144 (Supplement 1): 3469.

https://doi.org/10.1182/blood-2024-207676

Published: 2024

Journal Articles

Combination of Olverembatinib and VP Regimen for Newly Diagnosed Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Xu Tan, Guo Chen, Yingying Ma, Maihong Wang, Qin Wen, Hong Liu, Xi Zhang, Cheng Zhang

Blood (2024) 144 (Supplement 1): 1449.

https://doi.org/10.1182/blood-2024-206572

Published: 2024

Journal Articles

Venetoclax, Azacitidine, Combined with Low-Dose Cytarabine in Older Newly Diagnosed Acute Myeloid Leukemia：the Result of a Prospective, Multicenter, Open, Randomized Controlled Trials

Blood (2024) 144 (Supplement 1): 2902.

https://doi.org/10.1182/blood-2024-206513

Published: 2024

Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

Blood (2024) 144 (Supplement 1): 4196.

https://doi.org/10.1182/blood-2024-199983

Published: 2024

Journal Articles

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Blood (2023) 142 (Supplement 1): 3556.

https://doi.org/10.1182/blood-2023-189104

Published: 2023

Journal Articles

Association between Gut Microbiota and Leukemia: A Bidirectional Multivariable Mendelian Randomization Study

Dahua Lan, Jing-Kang Xiong, Cheng Zhang, Xi Zhang

Blood (2023) 142 (Supplement 1): 7244.

https://doi.org/10.1182/blood-2023-189071

Published: 2023

Journal Articles

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)

Blood (2023) 142 (Supplement 1): 320.

https://doi.org/10.1182/blood-2023-174420

Published: 2023

Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

Ying Wang, Xudong Wei, Dongmei Yan, Cheng Zhang, Hongsheng Zhou, Chunrong Tong, Heng Mei, Jie Jin, Ting Niu, Aibin Liang, Jienan Ren, Yiping Deng, Wei Jin, Yi Feng, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 1598–1600.

https://doi.org/10.1182/blood-2022-165002

Published: 2022

Journal Articles

Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I Trial

Ruihao Huang, Qin Wen, Xiaoqi Wang, Hongju Yan, Yingying Ma, Wang Mai-Hong, Xiao Han, Li Gao, Lei Gao, Cheng Zhang, Xi Zhang

Blood (2022) 140 (Supplement 1): 7450–7451.

https://doi.org/10.1182/blood-2022-170712

Published: 2022

Journal Articles

Decitabine Combined with FB3 As Conditional Regimen for Elderly/Weak Acute Myeloid Leukemia Patient with Allo-HSCT

Shichun Gao, Peiyan Kong, Lidan Zhu, Jia Liu, Liu Huanfeng, Lu Wang, Cheng Zhang, Li Gao, Lei Gao, Xi Zhang

Blood (2022) 140 (Supplement 1): 12835–12836.

https://doi.org/10.1182/blood-2022-169384

Published: 2022

Journal Articles

Amplifying Sting Activation By Bio-Inspired Nanomedicine for Targeted Acute Myeloid Leukemia Chemo- and Immunotherapy

Xiaoqi Wang, Ruihao Huang, Wei Wu, Jingkang Xiong, Qin Wen, Yunjing Zeng, Ting Chen, Jiali Li, Cheng Zhang, Jiang F. Zhong, Shijie Yang, Xi Zhang

Blood (2022) 140 (Supplement 1): 7804–7805.

https://doi.org/10.1182/blood-2022-169445

Published: 2022

Journal Articles

Phase II Multicenter, Randomized Controlled Study on Infusion of MSCs at 45 Days after Haplo-Hematopoietic Stem Cell Transplantation in the Prophylaxis of Gvhd

Ruihao Huang, Ting Chen, Sanbin Wang, Jishi Wang, Yi Su, Jing Liu, Peiyan Kong, Cheng Zhang, Lei Gao, Li Gao, Xi Zhang

Blood (2022) 140 (Supplement 1): 7651–7652.

https://doi.org/10.1182/blood-2022-169431

Published: 2022

Journal Articles

Role of Donor-Derived CD19.CAR-T Cells in Treating Patients That Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

Cheng Zhang, MD PhD, Lei Gao, Yao Liu, Li Gao, Pei-Yan Kong, Jun Liu, Ruihao Huang, Ying-Ying Ma, Defu Zeng, MD PhD, Qing-Hui Xiong, Wei-Ling Mei, Jia Liu, Peng-Fei Jiang, Xun Ye, De-Ping Han, Wei Cao, Xi Zhang

Blood (2019) 134 (Supplement_1): 4561.

https://doi.org/10.1182/blood-2019-128262

Published: 2019

Journal Articles

A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma

Hua Zhang, Lei Gao, Li Liu, Jishi Wang, PhD, Sanbin Wang, Li Gao, Cheng Zhang, MD PhD, Yao Liu, Peiyan Kong, Jia Liu, Jiaping He, Yu Han, Hua Shi, Yan He, Xun Ye, Yi Zhao, Wei Cao, Lianjun Shen, Xi Zhang

Blood (2019) 134 (Supplement_1): 3147.

https://doi.org/10.1182/blood-2019-131056

Published: 2019

Journal Articles

CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside

Cheng Zhang, Jiaping He, Li Liu, Jishi Wang, PhD, Sanbin Wang, Ligen Liu, Lei Gao, Li Gao, Yao Liu, Peiyan Kong, Jia Liu, Yu Han, Yongliang Zhang, Zhe Sun, Xun Ye, Yan He, Lianjun Shen, MD PhD, Wei Cao, Xi Zhang

Blood (2019) 134 (Supplement_1): 1340.

https://doi.org/10.1182/blood-2019-128006

Published: 2019

Journal Articles

Study on Use of CAR-T Cells in Allogeneic Hematopoietic Stem Cell Transplantation

Jun Liu, Xu Tan, Ma Ying-Ying, Wang Mai-Hong, Yao Liu, Gao Lei, Kong Peiyan, Cheng Zhang, MD PhD, Xi Zhang, Defu Zeng, MD

Blood (2018) 132 (Supplement 1): 5225.

https://doi.org/10.1182/blood-2018-99-114287

Published: 2018

Journal Articles

Decitabine Combined with FB3 As Conditional Regimen for Elderly Acute Myeloid Leukemia Patient with Allogeneic Hematopoietic Stem Cell Transplantation

Shichun Gao, Jia Liu, Kong Peiyan, Li Gao, Cheng Zhang, MD PhD, Yao Liu, Hongju Yan, Lidan Zhu, Defu Zeng, MD, Lei Gao, Xi Zhang

Blood (2018) 132 (Supplement 1): 2108.

https://doi.org/10.1182/blood-2018-99-115926

Published: 2018

NARROW

Reduced Incidence of Severe Hemorrhagic Cystitis in Prophylaxis Infusion of Mensenchymal Stromal Cells for Gvhd, a Secondary Endpoints in a Randomized,Multiple Center Clinical Tria

A Single-Arm, Multi-Center, Retrospective Clinical Study of Cba Preconditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Acute Leukemia

Efficacy and Safety of Decitabine Combined with FB3 As Conditional Regimen for Elderly/Frail Acute Myeloid Leukemia Patient with Allo-HSCT

Comparison of the Efficacy and Adverse Effects of Recipient-Derived Versus Donor-Derived CAR-T Cell Therapy for Post-Transplant Relapse in B-ALL

Combination of Olverembatinib and VP Regimen for Newly Diagnosed Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Venetoclax, Azacitidine, Combined with Low-Dose Cytarabine in Older Newly Diagnosed Acute Myeloid Leukemia：the Result of a Prospective, Multicenter, Open, Randomized Controlled Trials

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Association between Gut Microbiota and Leukemia: A Bidirectional Multivariable Mendelian Randomization Study

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I Trial

Decitabine Combined with FB3 As Conditional Regimen for Elderly/Weak Acute Myeloid Leukemia Patient with Allo-HSCT

Amplifying Sting Activation By Bio-Inspired Nanomedicine for Targeted Acute Myeloid Leukemia Chemo- and Immunotherapy

Phase II Multicenter, Randomized Controlled Study on Infusion of MSCs at 45 Days after Haplo-Hematopoietic Stem Cell Transplantation in the Prophylaxis of Gvhd

Role of Donor-Derived CD19.CAR-T Cells in Treating Patients That Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma

CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside

Study on Use of CAR-T Cells in Allogeneic Hematopoietic Stem Cell Transplantation

Decitabine Combined with FB3 As Conditional Regimen for Elderly Acute Myeloid Leukemia Patient with Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only